Long time use compound preparation for treating diabetes

A compound preparation and diabetes technology, applied in the field of compound preparations for the treatment of diabetes, can solve problems such as threats to the life safety of diabetic patients

Inactive Publication Date: 2005-10-26
PFICKER PHARMA
View PDF0 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Focusing on the treatment of a certain symptom alone will only have a small effect. If a comprehensive overall treatment is not carried out, it may have disastrous consequences such as acute and chronic complications of diabetes, which will threaten the life safety of diabetic patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] 1. The composition of the active ingredients is slightly different according to the difference between men and women, see the table below for details.

[0077]

active ingredient

Dosage

female

male male

Vitamin A (Vitamin A)

5000I.U.

5000I.U.

Vitamin C (Vitamin C)

500mg

580mg

Vitamin D (Vitamin D)

400I.U.

400I.U.

Vitamin E (Vitamin E)

440I.U.

460I.U.

Vitamin K (Vitamin K)

20 micrograms

20 micrograms

Vitamin B1 (Thiamin)

1.5 mg

1.5 mg

Vitamin B2 (Riboflavin)

1.7 mg

1.7 mg

Vitamin B3 (Niacin)

20 mg

20 mg

Vitamin B6

3 mg

3 mg

Vitamin B12

25 micrograms

25 micrograms

Vitamin H (Biotin)

20 micrograms

30 micrograms

Vitamin B5 (Pantothenic

Acid)

10 mg

10 mg

Folic Acid

800 micrograms

800 micrograms

Calcium

400mg

200mg

Phospho...

Embodiment 2

[0087] Sample 2 was prepared according to the same procedure as in Example 1, except that the formula shown in Table 2 was used.

[0088]

[0089] Coenzyme Q10

Embodiment 3

[0091] Sample 3 was prepared according to the same procedure as in Example 1, except that the formula shown in Table 3 was used. This formula is for patients with severe diabetes.

[0092]

[0093] Boron

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A compound medicine for preventing and treating diabetes and its complications contains VE, chromium pyridylformate, Se, xanthophyll, folic acid, VC, lipoic acid, lycopene, Co-Q10, composite vitamine and minerals.

Description

Field of invention: [0001] The invention belongs to a compound preparation for treating diabetes, more precisely, it belongs to a compound preparation for safe and long-term blood sugar control and health care treatment of diabetes. Background of the invention: [0002] Diabetes is a disease caused by the body's inability to produce, or even if it produces, the inability to use insulin normally. Insulin deficiency is divided into two types: one is type I diabetes caused by absolute insulin deficiency, and the other is type II diabetes caused by relative insulin deficiency, or insulin deficiency but its effect is weakened. Both conditions cause blood sugar to rise. [0003] Diabetes is a lifelong disease that cannot be cured. It is a common and frequently-occurring disease with a long course of disease and is prone to concurrent systemic nerve, microvascular, and macrovascular lesions. With the change of human eating habits, excessive intake of high-calorie food and reducti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/355A61K31/375A61K31/381A61K31/4164A61K31/4985A61K31/55A61K33/04A61K33/30A61K45/06
CPCA61K31/355A61K31/381A61K33/04A61K31/4985A61K31/4164A61K33/30A61K31/375A61K45/06A61K31/55A61P3/10A61K2300/00
Inventor 叶红平朱作霖孙萌
Owner PFICKER PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap